menu
    • menu

    Company profile for SNIPR Biome

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are the CRISPR and Gene Therapy of the Microbiome company! The precision killing of bacteria has the impact to revolutionize the management of untreatable and difficult-to-treat infections as well as complex diseases directly impacted by the human microbiota. Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SNIPR BiomeDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Lersø Parkallé 44 2100 Copenhagen
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sniprbiome.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sniprbiome/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SNIPR Biome: First Patient Dosed in Phase 1b Trial of SNIPR001
    SNIPR Biome: First Patient Dosed in Phase 1b Trial of SNIPR001

    12 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/12/3098051/0/en/SNIPR-BIOME-Announces-First-Patient-Dosed-in-its-Phase-1b-Clinical-Trial-of-SNIPR001-in-Patients-with-Hematological-Cancer.html

    GLOBENEWSWIRE
    12 Jun 2025
    Share Share
    SNIPR Biome Secures Patent For Novel CRISPR-Cas System
    SNIPR Biome Secures Patent For Novel CRISPR-Cas System

    24 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/24/3030923/0/en/SNIPR-Biome-Strengthens-IP-Portfolio-with-Patent-Granted-for-a-Novel-CRISPR-Cas-System.html

    GLOBENEWSWIRE
    24 Feb 2025
    Share Share
    SNIPR Biome Funded to Develop CRISPR Medicines for EED in Pregnant Women
    SNIPR Biome Funded to Develop CRISPR Medicines for EED in Pregnant Women

    28 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/28/2905665/0/en/SNIPR-Biome-receives-funding-for-the-development-of-CRISPR-medicines-to-improve-Environmental-Enteric-Dysfunction-EED-in-pregnant-women.html

    GLOBENEWSWIRE
    28 Jun 2024
    Share Share
    SNIPR Gets CARB-X Funding For CRISPR-Medicine SNIPR001 Trial
    SNIPR Gets CARB-X Funding For CRISPR-Medicine SNIPR001 Trial

    22 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/22/2866554/0/en/SNIPR-Biome-receives-funding-from-CARB-X-to-support-advancement-of-CRISPR-medicine-SNIPR001-into-clinical-trials-in-haematological-cancer-patients.html

    GLOBENEWSWIRE
    22 Apr 2024
    Share Share
    SNIPR Biome reports positive clinical interim results for microbial gene therapy
    SNIPR Biome reports positive clinical interim results for microbial gene therapy

    31 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/snipr-biome-reports-positive-clinical-interim-results-for-groundbreaking-first-in-human-crispr-based-microbial-gene-therapy-301838233.html

    PR NEWSWIRE
    31 May 2023
    Share Share
    Small biotech turns CRISPR against bacteria
    Small biotech turns CRISPR against bacteria

    31 May 2023

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/small-biotech-turns-crispr-against-bacteria-reducing-e-coli-small-early-study

    Annalee Armstrong FIERCE BIOTECH
    31 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search